The therapeutic effects of KM-CP-met upon oral administration was tested in a slowly progressing ADPKD murine model using Pkd1fl/fl;Pax8-rtTA;Tet-O-Cre mice, which mimics the chronic nature of the human disease (56). The gene discussed is PAX8; the disease is autosomal dominant polycystic kidney disease.